CN101302208B - 抑制谷胱甘肽s-转移酶活性的化合物、其制备方法、其应用 - Google Patents
抑制谷胱甘肽s-转移酶活性的化合物、其制备方法、其应用 Download PDFInfo
- Publication number
- CN101302208B CN101302208B CN 200810008038 CN200810008038A CN101302208B CN 101302208 B CN101302208 B CN 101302208B CN 200810008038 CN200810008038 CN 200810008038 CN 200810008038 A CN200810008038 A CN 200810008038A CN 101302208 B CN101302208 B CN 101302208B
- Authority
- CN
- China
- Prior art keywords
- compound
- activity
- enzyme
- compounds
- gsts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- IQVQXVFMNOFTMU-FLIBITNWSA-N CCC/C=C(/C1=C2C=CCC1)\OC2=O Chemical compound CCC/C=C(/C1=C2C=CCC1)\OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810008038 CN101302208B (zh) | 2008-03-04 | 2008-03-04 | 抑制谷胱甘肽s-转移酶活性的化合物、其制备方法、其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810008038 CN101302208B (zh) | 2008-03-04 | 2008-03-04 | 抑制谷胱甘肽s-转移酶活性的化合物、其制备方法、其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101302208A CN101302208A (zh) | 2008-11-12 |
CN101302208B true CN101302208B (zh) | 2012-12-26 |
Family
ID=40112325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810008038 Expired - Fee Related CN101302208B (zh) | 2008-03-04 | 2008-03-04 | 抑制谷胱甘肽s-转移酶活性的化合物、其制备方法、其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101302208B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103735541B (zh) * | 2013-12-20 | 2016-01-20 | 上海中医药大学 | 一种阿魏酸松柏酯的用途 |
CN103910700A (zh) * | 2014-03-20 | 2014-07-09 | 无锡药科美生物科技有限公司 | 抑制乙酰胆碱酯酶活性的化合物及其应用 |
CN105079059B (zh) * | 2015-09-07 | 2020-03-31 | 宜诺(天津)医药工程有限公司 | 当归提取物及提取方法 |
CN105445209A (zh) * | 2015-12-31 | 2016-03-30 | 中国烟草总公司郑州烟草研究院 | 一种筛选烟用农药或安全剂的方法及应用 |
CN105669692B (zh) * | 2016-03-08 | 2018-02-06 | 山西大学 | 一种苯酞类二聚体化合物的提取方法和用途 |
CN108830041B (zh) * | 2018-06-20 | 2021-07-13 | 安徽工程大学 | 一种α-葡萄糖苷酶抑制剂的虚拟筛选方法 |
CN108822110B (zh) * | 2018-08-01 | 2020-03-13 | 山东大学 | 含芳香杂环的a,β-不饱和酮化合物及其制备方法与应用 |
CN109553590B (zh) * | 2018-11-22 | 2022-04-26 | 东南大学 | 具有谷胱甘肽巯基转移酶抑制功能的化合物及其制备方法 |
CN112057494B (zh) * | 2020-09-04 | 2022-04-08 | 湖南中医药大学 | 獐牙菜的提取物在制备抑制谷胱甘肽s-转移酶活性的药物中的应用 |
CN112063685B (zh) * | 2020-09-04 | 2024-02-02 | 湖南中医药大学 | 谷胱甘肽s-转移酶抑制剂的筛选方法与应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100562314C (zh) * | 2003-05-14 | 2009-11-25 | 帝斯曼知识产权资产管理有限公司 | 苯并呋喃酮衍生物用于治疗和预防糖尿病的用途 |
-
2008
- 2008-03-04 CN CN 200810008038 patent/CN101302208B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101302208A (zh) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101302208B (zh) | 抑制谷胱甘肽s-转移酶活性的化合物、其制备方法、其应用 | |
Cai et al. | Protective effects of Salvia miltiorrhiza on adenine-induced chronic renal failure by regulating the metabolic profiling and modulating the NADPH oxidase/ROS/ERK and TGF-β/Smad signaling pathways | |
Waalkes et al. | The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer | |
Liu et al. | Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity | |
Reshef et al. | Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET | |
Han et al. | Hypouricemic effects of extracts from Urtica hyperborea Jacq. ex Wedd. in hyperuricemia mice through XOD, URAT1, and OAT1 | |
Dey et al. | Pelargonidin mediated selective activation of p53 and parp proteins in preventing food additive induced genotoxicity: an in vivo coupled in silico molecular docking study | |
Huang et al. | Two glutathione S‐transferase inhibitors from Radix Angelicae sinensis | |
Zhu et al. | A rapid and sensitive UHPLC-MS/MS method for the determination of ziyuglycoside I and its application in a preliminary pharmacokinetic study in healthy and leukopenic rats | |
Wu et al. | The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study | |
Jong et al. | Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging | |
Chen et al. | Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation | |
Tamano et al. | Preferential uptake of zinc, manganese, and rubidium in rat brain tumor | |
Eder et al. | A phase I trial of daily oral 4′-N-benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies | |
Ivankin et al. | Monoterpene substituted thiazolidin-4-ones as novel TDP1 inhibitors: Synthesis, biological evaluation and docking | |
Bolzati et al. | Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc (N)(DBODC)(PNP5)]+ | |
Wei et al. | A combinatorial target screening strategy for deorphaning macromolecular targets of natural product | |
Cao et al. | Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo | |
CN102584768B (zh) | 3-硝基-8-乙氧基-2h-苯并吡喃类化合物及其制备方法与应用 | |
US11926677B2 (en) | Peptides and uses thereof for treating cancer | |
CN107586284B (zh) | 一种2-芳基苯并呋喃类衍生物在制备痛风药物中的用途 | |
CN101342146A (zh) | 格列美脲片的制备方法 | |
Piao et al. | Mitochondrial toxicants in Xian-Ling-Gu-Bao induce liver injury by regulating the PI3K/mTOR signaling pathway: an in vitro study | |
CN114426470A (zh) | 人pcid2蛋白在制备或筛选抗肿瘤药物中的应用及具有抗肿瘤活性的化合物 | |
Hasin et al. | Validation of spectrophotometric dissolution method for modified release trimetazidine pharmaceutical dosage form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LI SHAOJING Effective date: 20121115 Owner name: CENTRAL UNIVERSITY FOR NATIONALITIES Free format text: FORMER OWNER: LIU QINGSHAN Effective date: 20121115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Qingshan Inventor after: Li Shaojing Inventor before: Liu Qingshan Inventor before: Li Shaojing Inventor before: Lu Xinhua Inventor before: Du Guanhua Inventor before: Liu Ailin Inventor before: Cui Jian Inventor before: Xu Sifan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU QINGSHAN LI SHAOJING LU XINHUA DU GUANHUA LIU AILIN CUI JIAN XU SIFAN TO: LIU QINGSHAN LI SHAOJING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121115 Address after: 100081 Beijing, Zhongguancun, South Street, No. 27, No. Applicant after: Central University for Nationalities Address before: 100081 Beijing, Zhongguancun, South Street, No. 27, No. Applicant before: Liu Qingshan Applicant before: Li Shaojing |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20130304 |